A TLR7 agonist enhances the anti-tumour efficacy of obinutuzumab through an NK cell/CD4 dependent mechanism in a murine lymphoma model
Cheadle, E., Lipowska-Bhalla, G., Fagnano, E., Klein, C., Dovedi, S., Honeychurch, J., Illidge, T.Volume:
61
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)61746-x
Date:
July, 2016
File:
PDF, 59 KB
english, 2016